Alkem Laboratories launches generic Empagliflozin in India at reduced cost
Empanorm and its combinations introduced at prices approximately 80 per cent lower than innovator products
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Alkem Laboratories
Alkem Laboratories announces strategic acquisitions of Adroit Biomed and Bombay Ortho Industries
Alkem Laboratories acquires 100 per cent stakes in Adroit Biomed and Bombay Ortho Industries for INR 140 crore and INR 147 crore,…
Alkem Laboratories Launch MediSamvad digital platform for healthcare professionals
New platform provides healthcare professionals with global medical updates, webinars, and continuous education resources
Alkem signs agreement with US-based Sonnet BioTherapeutics to develop, commercialise its drug…
Under the licensing agreement, Alkem will carry out the clinical development of “SON-080” in India to enable global and India…
Alkem Laboratories denies claims of substandard quality for Pan-D and Clavam 625
Company asserts that reported samples are spurious and not manufactured by Alkem
Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
Alkem MedTech signs agreement with Exactech to manufacture and market knee and hip replacement…
Exactech develops, manufactures and markets joint replacement implants, surgical instruments and smart technologies that enhance…
US FDA completes inspection at Alkem’s Baddi facility
The Inspection was classified as Voluntary Action Indicated (VAI)
Building resilience to regulatory risks
Future growth of Indian pharma companies hinge on their ability to successfully navigate regulatory inspections
Alkem Laboratories brands API business as Alkem Activa
Alkem Activa plans to expand its capacity, incorporating technologies like biocatalytic and continuous manufacturing technologies